🙃 Inverse Cramer Weekly Update – Sep 1
MONDAY AUG 26
It is without a doubt one of the shortest stock in the market. Every time bad happens in the cosmetics group, people come down on it. But then you have to buy, but you don’t buy after the first quarter, you buy it after a couple of days. Let’s wait till Thursday and take a look where it is.
-On Elf Beauty ($ELF)
I don’t like B&G Foods. I know it’s got that dividend, maybe it bounces, but the fact is it’s a bunch of warmed under brands put together under one roof. That game does’’t work anymore, especially in Mad Money.
-On B&G Foods ($BGS)
It’s a trading stock. It’s not investable. Central nervous system drugs is so rare and I can’t recommend that stock. It’s too high risk for me.
-On Acadia Pharma ($ACAD)
I am believing that SoFi is maybe the right one. I see the risk-reward to be very positive.
-On SoFi Technologies ($SOFI)
I believe Michael Dell. The stock is down from $179 to $111, that seems to be decent risk-reward. I’m saying you can buy it.
-On Dell Technologies ($DELL)
TUESDAY AUG 27
No Calls.
WEDNESDAY AUG 28
We are back in that moment where we will not recommend a company that’s losing a ton of money.
-On Serve Robotics ($SERV)
This stock can higher. This is precisely the kind of stock you should buy at this stage of the cycle. Hold on.
-On Builders Firstscre ($BLRD)
I think you’re in great shape. I’m told, and I read a piece that says they got this new honey chicken—it doesn’t sound like junk food to me; it sounds like good food to me. That’s why Chipotle is probably going down, and I like it. Brian Niccol is a twofer; I like him at Starbucks.
-On Chipotle Mexican ($CMG)
I think Vertex is great. I like the fact on what they are doing in terms of opiates. This is a great company, and no one talks about it. We have them on, and I think they are brilliant.
-On Vertex Pharma ($VRTX)
THURSDAY AUG 29
This is a very speculative situation. It is up huge. I don’t know if I’m coming at the right level, but I have to tell you, every time there is an immunity compromise, there’s some big money down the road. They sound like they have something breakthrough.
-On Adma Biologics ($ADMA)
I think this is a very difficult situation. They need to make a lot of money, and they have been trying. In the end, we need companies that make money. If they don’t pull out with their losses, it doesn’t matter.
-On MP Materials ($MP)
There’s no investing in this; at this point, it is speculating. You can certainly speculate in any biotech that you want but understand that you’ll have to be able to lose a lot of money to make a lot of money.
-On Delcath Systems ($DCTH)
FRIDAY AUG 30
No calls.
WEEKEND BONUS
CRAMER CLASSICS
That’s a wrap. As always, we’ll be following Cramer’s every move, so you can do the opposite.
See you tomorrow,
-IC